Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes.
Company Details
- Employees
- 5
- Founded
- 2022
- Address
- Suite 2, Orchard Brae House, 30 Queensferry Road,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.fitabeo.com
- Keywords
- Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, Neurology.
- HQ
- Edinburgh
Fitabeo Therapeutics Questions
Fitabeo Therapeutics's website is http://www.fitabeo.com
Fitabeo Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/fitabeo
Fitabeo Therapeutics has
5 employees.
View email and phone details for 5
employees at Fitabeo Therapeutics.
Fitabeo Therapeutics's industry is
Pharmaceutical Manufacturing
Fitabeo Therapeutics's top competitors are
Tay Therapeutics Ltd,
Enterobiotix,
Qnostics,
Ilc Therapeutics,
Scotland's Life Sciences Conference & Awards,
Bdd,
Reprocell,
Trisalus Life Sciences,
Bioascent,
Glox Therapeutics Ltd..
Fitabeo Therapeutics's categories are Pharmaceutical Manufacturing
Fitabeo Therapeutics's founding year is 2022
